Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Hormonal Contraceptives Market is predicted to reach US$ by 2030 from US$ 18.21 billion in 2021, and to grow at a CAGR of 4.3% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Hormone (Progestin Only and Combined Hormones), by Product (Hormonal Implants, Hormonal Intrauterine Devices, Oral Contraceptives and Skin Patches), by Age-Group (15-24 Years, 25-34 Years, 35-44 Years and 45 Years & Above), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Gynecology/Fertility Clinics)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Novartis AG, Allergan plc., Apothecus Pharmaceutical Corporation, Pfizer, Inc., Bayer AG, Merck & Co. Inc., Teva Pharmaceuticals Industries Ltd., Afaxys, Inc., Lupin Pharmaceuticals, Mylan N.V., CooperSurgical Inc., and Johnson & Johnson Services, Inc./Janssen Pharmaceuticals Inc among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Hormonal Contraceptives - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Hormonal Contraceptives - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Hormonal Contraceptives - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Hormonal Contraceptives - ANALYSIS & FORECAST, BY REGION
North America Hormonal Contraceptives
1. North America Hormonal Contraceptives , by Country
1. US
2. Canada
1. North America Hormonal Contraceptives , by Product
2. North America Hormonal Contraceptives , by Type
3. North America Hormonal Contraceptives , by Gender
4. North America Hormonal Contraceptives , by Sales Channel
3. Europe Hormonal Contraceptives
1. Europe Hormonal Contraceptives , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Hormonal Contraceptives , by Product
3. Europe Hormonal Contraceptives , by Type
4. Europe Hormonal Contraceptives , by Gender
5. Europe Hormonal Contraceptives , by Sales Channel
4. Asia Pacific Hormonal Contraceptives
1. Asia Pacific Hormonal Contraceptives , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Hormonal Contraceptives , by product
3. Asia Pacific Hormonal Contraceptives , by Type
4. Asia Pacific Hormonal Contraceptives , by Gender
5. Asia Pacific Hormonal Contraceptives , by Sales Channel
5. Rest of the World Hormonal Contraceptives
1. Rest of the World Hormonal Contraceptives , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Hormonal Contraceptives , by Product
3. Rest of the World Hormonal Contraceptives , by Type
4. Rest of the World Hormonal Contraceptives , by Gender
5. Rest of the World Hormonal Contraceptives , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 65
Request Sample 
Request Discount 
Inquire Before Buy
